Table of contents

Original research

• Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients (27 April, 2022)

  Yan Qin, Zhe Chen, Shuai Gao, Yun Shen, Yanrong Ye
• Development and implementation of medication-related clinical rules for obstetrics, gynaecology, and paediatric outpatients (6 May, 2022)

  Quanyao Chen, Luwei Wang, Min Lin, Weida Chen, Wen Wu, Yao Chen
• Classification of non-antineoplastic intravenously administered drugs according to their toxicity risk: the path towards safe drug administration (19 May, 2022)

  Teresa Giménez Poderós, Juan José Fernández Cabero, Marta Valero Domínguez
• Frequency of measuring body weight in (sub)populations of patients with cancer treated with chemotherapy (23 May, 2022)

  Shirley Kemps, Mostafa Soleyman, Harmen Huls, Mariette Labots, Mirjam Crul
• Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study (22 June, 2022)

  Stephanie Heinemann, Jonas Klemperer, Eva Hummers, Roland Nau, Wolfgang Himmel
• Determination of plasma uracil as a screening for dihydropyrimidine dehydrogenase deficiency: clinical application in oncological treatments (21 June, 2022)

  Eduardo Tejedor-Tejada, Daniel Rubio Calvo, Antonio García Andreo
• Factors associated with potential drug–drug interactions in psychiatric inpatients (21 June, 2022) Free

  Anica Ranković, Iva Milentijevic, Slobodan Jankovic
• Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials (19 July, 2022)

  Mona Abdel-Tawab, Markus Waßmuth, Florian Gegenfurtner, Andrea Hawe, Jan H Schefe, Anke M Strunz, Joachim Wübert
• Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study (19 July, 2022)

  David Young, Fraser Cummings, Susan Latter
• Real-world effectiveness and durability of dual antiretroviral therapy in HIV-infected patients (26 July, 2022)

  Laia Pérez-Cordón, Azhara Sánchez, Sergio Marin, Lluis Force, Mateu Serra-Prat, Elisabet Palomera, Lluis Campins
• Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years (12 August, 2022)

  Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini, Angelora Di Risio